CSIMarket Company Name, Ticker, Competitors, else..
 

Kyverna Therapeutics Inc   (NASDAQ: KYTX)
Other Ticker:  
 

Kyverna Therapeutics Inc 's

Competitiveness



 
 

KYTX Sales vs. its Competitors Q1 2025






Revenue Growth Comparisons




Net Income Comparison



<<  KYTX Stock Performance Comparisons





*Market share is calculated based on total revenue.

  News about Kyverna Therapeutics Inc Contracts

Legal Implications of Kyverna Therapeutics IPO A Crucial Notice for Investors

December 21, 2024
 In the evolving landscape of biotech investments, the recent announcement from Rosen Law Firm regarding Kyverna Therapeutics, Inc. (NASDAQ: KYTX) has highlighted a significant potential legal battle stemming from the company s initial public offering (IPO). Investors and stakeholders should be aware of the implications of this development, particularly with the looming deadline for class action participation.On December 20, 2024, Rosen Law Firm, a well-regarded entity in investor rights advocacy, urged investors in Kyverna Therapeutics to seek legal counsel before the critical lead plaintiff deadline of February 7, 2025. This announcement pertains to purchasers of Kyverna s common stock, especially those wh...





Publicly Traded Peers of Kyverna Therapeutics Inc




Immix Biopharma Inc
Share Performance



 +1.82%
This Year
Immix Biopharma Inc
Profile

ImmIx Biopharma Inc is a biotechnology company that focuses on developing novel therapeutics for the treatment of cancer. Their business model involves conducting extensive research and development to discover and optimize drug candidates, followed by preclinical and clinical testing to assess their safety and effectiveness. They aim to collaborate with pharmaceutical companies or seek licensing agreements to further develop and commercialize their biopharmaceutical products.

More about Immix Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 63.703 mill. $ - mill. $ -21.698 mill.




Sources: Kyverna Therapeutics Inc and all companies mentioned above in this report


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com